The 14th Annual EuroTIDES 2013 is a conference dedicated to developments in oligonucleotides and covers topics such as:
- Benchmark the latest Pre-Clinical and Clinical updates from 10+ leading companies
- The latest clinical findings and related challenges
- In vivo delivery and synthesising RNA and analogues at scale
- New and novel approaches to overcome the delivery challenge
- Strategy industry insights
- Oligos for Orphan Diseases
- Manufacturing capability, regulatory strategy and manufacturing control strategies
- Reduce cost and optimize your manufacturing strategy
- Therapeutic oligonucleotide drug development and GSK
- A novel second generation antisense oligonucleotide for treatment of the rare genetic disorder, Homozygous Familial Hypercholesterolemia
The 14th Annual EuroTIDES 2013 brings together attendees from Pharma and Biotech companies.